Edition:
India

People: Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

0.85USD
13 Sep 2019
Change (% chg)

$-0.00 (-0.12%)
Prev Close
$0.85
Open
$0.86
Day's High
$0.87
Day's Low
$0.84
Volume
59,143
Avg. Vol
98,796
52-wk High
$4.25
52-wk Low
$0.70

Marguglio, David 

Mr. David J. Marguglio is Senior Vice President - Corporate Development, Director of Adamis Pharmaceuticals Corporation. Mr. Marguglio joined the Company as Vice President, Business Development and Investor Relations, and a director in April 2009 in connection with the closing of the merger transaction with Old Adamis, and has held positions with the Company of Senior Vice President of Corporate Development and, since March 2017, Senior Vice President and Chief Business Officer. Mr. Marguglio was a co-founder of Old Adamis and served as its Vice President of Business Development and Investor Relations, and a director, since its inception in June 2006 until April 2009. From 1996 to 2006, he held various positions with Citigroup Global Markets, Smith Barney and Merrill Lynch. Before entering the financial industry, from 1994 to 1996, he founded and ran two different startup companies, the latter of which was eventually acquired by a Fortune 100 company. From 1993 to 1994, he served as financial counsel for the commercial litigation division of a national law firm. He received a degree in finance and business management from the Hankamer School of Business at Baylor University.

Basic Compensation

Total Annual Compensation, USD 328,000
Restricted Stock Award, USD 700,000
Long-Term Incentive Plans, USD --
All Other, USD 428,638
Fiscal Year Total, USD 1,456,640

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Williams

540,000

Dennis Carlo

2,562,760

Robert Hopkins

1,307,310

David Marguglio

1,456,640

Karen Daniels

259,891

Thomas Moll

--
As Of  31 Dec 2017